Ketamine mouthwash versus placebo in the treatment of severe oral mucositis pain in children with cancer: A randomized double‐blind placebo‐controlled trial

S Prakash, JP Meena, AK Gupta… - Pediatric Blood & …, 2020 - Wiley Online Library
Background and aims Oral mucositis (OM) is a common and distressing toxicity in children
on chemotherapy. There are a limited number of safe and effective therapeutic options …

Long‐term safety and efficacy of sublingual ketamine troches/lozenges in chronic non‐malignant pain management

B Maudlin, SB Gibson, A Aggarwal - Internal Medicine Journal, 2022 - Wiley Online Library
Background Chronic non‐malignant pain is a disabling condition that results in a reduction
in function and quality of life when inadequately managed. Sublingual ketamine has been …

[HTML][HTML] La ketamina en el tratamiento del dolor crónico según medicina basada en la evidencia

F Neira Reina, JL Ortega García - Revista de la Sociedad …, 2016 - SciELO Espana
La ketamina es un antagonista no competitivo de los receptores NMDA y tiene un amplio
mecanismo de acción que involucra, además, a los receptores AMPA, kainato, ácido …

The Use of Ketamine for Malignant and Nonmalignant Chronic Pain in Children: A Review of Current Evidence

K AlGhamdi, K Sadler - Journal of Pain & Palliative Care …, 2024 - Taylor & Francis
Chronic pain in children continues to pose significant challenges. The pharmacological
approach most often revolves around trials and errors, expert opinions, and extrapolation of …

[PDF][PDF] Comparison of the effects of oral vs. peritonsillar infiltration of ketamine in pain reduction after tonsillectomy: a randomized clinical trial

A Norouzi, A Jafari, HRK Vishteh, S Fateh - group, 2015 - aub.edu.lb
Background: although oral ketamine has been used in some cases to reduce pain in
children, the use of this drug to reduce pain after tonsillectomy has not been studied yet …

Extended release pharmaceutical formulation

PW Glue, NJ Medlicott - US Patent 10,744,094, 2020 - Google Patents
US10744094B2 - Extended release pharmaceutical formulation - Google Patents
US10744094B2 - Extended release pharmaceutical formulation - Google Patents Extended …

[HTML][HTML] Refractory symptoms in paediatric palliative care: can ketamine help?

F Benini, S Congedi, L Giacomelli, S Papa… - Drugs in …, 2021 - ncbi.nlm.nih.gov
Background One of the main challenges for paediatric palliative care (PPC) is the
management of concomitant, different and severe symptoms that frequently affect the quality …

Extended release pharmaceutical formulation

PW Glue, NJ Medlicott, PW Surman - US Patent 11,045,424, 2021 - Google Patents
US11045424B2 - Extended release pharmaceutical formulation - Google Patents US11045424B2
- Extended release pharmaceutical formulation - Google Patents Extended release …

Extended release pharmaceutical formulation

PW Glue, NJ Medlicott - US Patent 10,869,838, 2020 - Google Patents
8,137,711 B2 8,309,060 B2 9,272,037 B2 9,533,982 B2 9,650,352 B2 9,867,830 B2
2005/0038062 A1 2009/0202634 Al 2013/0217615 A1 2013/0281388 A1 2014/0050787 Al …

Dolor al final de la vida en cuidados paliativos (excluida la perinatología)

S Frache, A Mercier, M Letellier, C Lafay, M Alexandre… - EMC-Pediatría, 2024 - Elsevier
Tratar el dolor de los niños al final de la vida es tanto un imperativo deontológico como
ético. Escuchar a los niños hablar de su dolor y de su cuerpo es una de las formas en que …